The Use of Lactobacillus Plantarum 299v in Treatment of Cancer Patients Who Received Home Enteral Nutrition

NCT ID: NCT03940768

Last Updated: 2020-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-10

Study Completion Date

2020-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess the impact of Lactobacillus plantarum 299v on nutritional status, tolerance of enteral diet and the quality of life. Administration of this probiotic may potentially improve nutritional status and tolerance of enteral diet. It also may provide positive effect on quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study group consists of patients with cancer who are qualified for home enteral nutrition in Nutritional Counselling Center Copernicus in Gdansk. The control group will receive home enteral nutrition and placebo. The experimental group will receive home enteral nutrition and Lactobacillus plantarum 299v. The study is prospective and double-blind. The parameters for evaluation of nutritional status are: BMI, body mass analysis, level of total protein and albumin in blood serum, total lymphocyte count, NRS 2002 method. Assessment of the quality of life and tolerance of enteral diet will be done by questionaires.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lactobacillus plantarum 299v receivers

Sanprobi IBS (Lactobacillus plantarum 299v) 2 capsules per day for 4 weeks.

Group Type EXPERIMENTAL

Lactobacillus plantarum 299v

Intervention Type DIETARY_SUPPLEMENT

Administration of Lactobacillus plantarum 299v in cancer patients who receive home enteral nutrition.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Administration of placebo in cancer patients who receive home enteral nutrition.

Placebo receivers

Sanprobi IBS placebo 2 capsules per day for 4 weeks.

Group Type PLACEBO_COMPARATOR

Lactobacillus plantarum 299v

Intervention Type DIETARY_SUPPLEMENT

Administration of Lactobacillus plantarum 299v in cancer patients who receive home enteral nutrition.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Administration of placebo in cancer patients who receive home enteral nutrition.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lactobacillus plantarum 299v

Administration of Lactobacillus plantarum 299v in cancer patients who receive home enteral nutrition.

Intervention Type DIETARY_SUPPLEMENT

Placebo

Administration of placebo in cancer patients who receive home enteral nutrition.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age ≥18 yr.,
* the presence of cancer, artificial access to the alimentary tract (naso-gastric tube, gastrostomy, percutaneous endoscopic gastrostomy, jejunostomy, microjejunostomy),
* qualification for home enteral nutrition,
* written consent to take part in the study

Exclusion Criteria

* age \<18 yr.,
* patients requiring home parenteral nutrition,
* patients who are not being able to attend the visit in the study centre.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Gdansk

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Karolina Kaźmierczak-Siedlecka

Karolina Kaźmierczak-Siedlecka (nutritionist, PhD student - Department of Surgical Oncology)

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nutritional Counselling Centre Copernicus in Gdansk

Gdansk, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

References

Explore related publications, articles, or registry entries linked to this study.

Kazmierczak-Siedlecka K, Folwarski M, Skonieczna-Zydecka K, Ruszkowski J, Makarewicz W. The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial. Nutr J. 2020 Sep 11;19(1):98. doi: 10.1186/s12937-020-00598-w.

Reference Type DERIVED
PMID: 32917221 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MUGdansk1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Probiotics In Colorectal Cancer Patients
NCT00936572 COMPLETED PHASE2